Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

TTUHSC receives nearly $2.3 million in CPRIT grants to support cancer research

The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to four researchers from the Texas Tech University Health Sciences Center (TTUHSC).

12 Oct 2023

Is HPV infection a hidden risk factor for prostate cancer?

In a comprehensive meta-analysis published in Scientific Reports, researchers unveil a significant link between human papillomavirus (HPV) infection and increased risk of prostate cancer, highlighting the importance of considering normal prostate tissues over benign prostatic hyperplasia (BPH) as controls for more accurate conclusions.

8 Oct 2023

TikTok can be a valuable tool for promoting cervical cancer screening

TikTok and other short-form video platforms are booming in popularity -; for entertainment and for sharing information, including health information.

5 Oct 2023

Pharmacists can play key role in boosting HPV vaccination rates

HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer.

3 Oct 2023

Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms

Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms.

3 Oct 2023

The fight against cancer: a comprehensive assessment of preventable and treatable cases

Researchers presented the findings of a population-based study conducted across 185 countries to estimate premature deaths due to 36 different types of cancers in 2020, a leading cause of premature deaths worldwide.

29 Sep 2023

Gender inequalities worsen women’s access to cancer prevention, detection and care

Unequal power dynamics across society have resounding negative impacts on how women interact with cancer prevention, care and treatment.

26 Sep 2023

New guideline with preventive care recommendations aims to promote health equity in Canada

A comprehensive new guideline with 16 preventive care recommendations aims to promote health equity for people disadvantaged because of racism, sexism and other forms of discrimination.

25 Sep 2023

Cornell researchers receive NIH grant to launch new center for developing point-of-care diagnostic devices

An interdisciplinary team led by Cornell has received a five-year grant to launch a new center for engineering, testing and commercializing point-of-care diagnostic devices that will have international reach.

21 Sep 2023

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

11 Sep 2023

Promising new cervical cancer test fills in the gap missed by Pap tests

Researchers assessed a novel human papillomavirus (HPV) and host deoxyribonucleic acid (DNA) methylation score for adenocarcinoma in-situ (AIS) and cervical adenocarcinoma (ADC) screening.

8 Sep 2023

Novel test could improve detection of cervical adenocarcinoma

In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss.

7 Sep 2023

Myriad Genetics survey: Women have widespread confusion and misconceptions about ovarian cancer screening

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women.

7 Sep 2023

One in three men carry HPV: The ignored reservoir in the fight against cancer

One in three men over 15 globally have at least one incidence of genital HPV, underscoring the need to include males in HPV prevention strategies. The prevalence remains high from young adulthood through later life, particularly for high-risk HPV types linked to cancers.

6 Sep 2023

Mississippi’s cervical cancer deaths indicate broader health care problems

Shementé Jones knew something wasn't right. Her back hurt. She felt pain during sex.

5 Sep 2023

KFF Health News' 'What The Health?': 3 health policy experts you should know

In this special episode, host Julie Rovner, KFF Health News' chief Washington correspondent, interviews three noted health policy experts.

31 Aug 2023

Are we failing to bridge the gap in HPV vaccine coverage globally?

Study reveals stark global inequities in HPV vaccine coverage across 84 countries, finding that nations with the highest burden of cervical cancer often have the lowest vaccination rates. However, new WHO recommendations and an increase in vaccine supply may help narrow this gap and improve equitable access.

29 Aug 2023

NIH and VentureWell select winners and honorable mentions of the DEBUT Challenge

The National Institutes of Health and the higher education non-profit VentureWell have selected 10 winners and five honorable mentions of the Design by Biomedical Undergraduate Teams (DEBUT) Challenge, who are set to receive prizes totaling $145,000.

25 Aug 2023

Black and Hispanic individuals with second primary cancer have higher death rates, study finds

In new findings from researchers at the American Cancer Society (ACS), non-Hispanic Black individuals diagnosed with a second primary cancer (SPC) experienced 21% higher cancer-related death rates and 41% higher cardiovascular-related death rates compared with their non-Hispanic White counterparts.

4 Aug 2023

Adult cancer diagnoses reduced by half in April 2020 during the COVID-19 pandemic in the U.S

A new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by half in April 2020 during the COVID-19 pandemic in the United States. The largest decrease was for stage I cancers, resulting in a higher proportion of late-stage diagnoses.

2 Aug 2023